These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7022848)

  • 1. High- and low-dose prednisolone.
    Chan L; French ME; Oliver DO; Morris PJ
    Transplant Proc; 1981 Mar; 13(1 Pt 1):336-8. PubMed ID: 7022848
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective trial of high-dose versus low-dose prednisolone in renal transplant patients.
    Chan L; French ME; Beare J; Oliver DO; Morris PJ
    Transplant Proc; 1980 Jun; 12(2):323-6. PubMed ID: 6994300
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of methylprednisolone on first renal allograft rejection.
    Ahonen J; Häyry P; von Willebrand E; Eklund B; Lindström BL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):328-31. PubMed ID: 7022846
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled trial of low versus high dose oral steroid therapy in 100 cadaveric renal transplants.
    Buckels JA; Mackintosh P; Barnes AD
    Proc Eur Dial Transplant Assoc; 1981; 18():394-9. PubMed ID: 7036158
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term follow-up of a prospective trial of low-dose versus high-dose steroids in cadaveric renal transplantation.
    Walker RG; d'Apice AJ; Mathew TH; Jacob C; Hardie IR; Menzies BO; Miach PJ
    Transplant Proc; 1987 Apr; 19(2):2825-8. PubMed ID: 3551219
    [No Abstract]   [Full Text] [Related]  

  • 6. A trial of low dose steroid in renal transplantation.
    Hariharan S; Raju PV; Gopalakrishnan G; Pandy AP; Jacob CK; Shastry JC; Kirubakaran MG
    J Assoc Physicians India; 1987 Jun; 35(6):429-30. PubMed ID: 3308836
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of fine-needle aspiration cytology in the monitoring of the in situ inflammatory response of kidney allograft rejection and the impact of glucocorticosteroids on the inflammation.
    Häyry B; von Willebrand E; Ahonen J; Lindström BL; Eklund B
    Transplant Proc; 1980 Jun; 12(2):331-4. PubMed ID: 6994302
    [No Abstract]   [Full Text] [Related]  

  • 8. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of high-dose intravenous methylprednisolone with low-dose oral prednisolone in acute renal allograft rejection in children.
    Orta-Sibu N; Chantler C; Bewick M; Haycock G
    Br Med J (Clin Res Ed); 1982 Jul; 285(6337):258-60. PubMed ID: 6807439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical value of antilymphocyte antibodies.
    Cosimi AB
    Transplant Proc; 1981 Mar; 13(1 Pt 1):462-8. PubMed ID: 7022874
    [No Abstract]   [Full Text] [Related]  

  • 11. Sixteen months experience with cyclosporin-A in human kidney transplantation.
    Sweny P; Farrington K; Younis F; Varghese Z; Baillod RA; Fernando ON; Moorhead JF
    Transplant Proc; 1981 Mar; 13(1 Pt 1):365-7. PubMed ID: 7022854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of ATG for reversal of acute allograft rejection.
    Nowygrod R; Appel G; Hardy MA
    Transplant Proc; 1981 Mar; 13(1 Pt 1):469-72. PubMed ID: 7022875
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma exchange in acute renal allograft rejection: is a controlled trial really necessary?
    Power D; Nicholls A; Muirhead N; MacLeod AM; Engeset J; Catta GR; Edward N
    Transplantation; 1981 Aug; 32(2):162-3. PubMed ID: 7027552
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of massive pulse steroid therapy on the water content of the rat brain.
    Cerilli J; Miller JA
    Transplantation; 1972 Sep; 14(3):403-5. PubMed ID: 4564935
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of antilymphoblast globulin in the treatment of renal allograft rejection.
    Howard RJ; Condie RM; Sutherland DE; Simmons RL; Najarian JS
    Transplant Proc; 1981 Mar; 13(1 Pt 1):473-4. PubMed ID: 7022876
    [No Abstract]   [Full Text] [Related]  

  • 16. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antilymphocyte globulin (ALG) reverses "irreversible" allograft rejection.
    Light JA; Alijani MR; Biggers JA; Oddenino K; Reinmuth B
    Transplant Proc; 1981 Mar; 13(1 Pt 1):475-81. PubMed ID: 7022877
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal transplant rejection after gradual withdrawal of prednisolone.
    Robertson AJ; Gibbs J; Potts R; Brown RA; Browning MC; Beck JS
    Br Med J; 1980 Jul; 281(6235):305-6. PubMed ID: 7000255
    [No Abstract]   [Full Text] [Related]  

  • 19. Passive enhancement of cadaver renal allografts: a prospective randomized trial of F(ab')2 therapy.
    Wilson RE; Garovoy MR; Strom TB; Lowry RP; Busch GJ; Vineyard GC; Tilney NL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):531-2. PubMed ID: 7022888
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
    Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif A; Foda MA
    Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.